Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 1
1956 1
1959 1
1961 4
1962 11
1963 20
1964 9
1965 9
1966 11
1967 7
1968 12
1969 16
1970 17
1971 15
1972 6
1973 11
1974 9
1975 11
1976 9
1977 10
1978 19
1979 16
1980 25
1981 39
1982 41
1983 42
1984 51
1985 57
1986 48
1987 42
1988 40
1989 40
1990 59
1991 57
1992 65
1993 44
1994 60
1995 59
1996 74
1997 70
1998 92
1999 55
2000 45
2001 36
2002 43
2003 48
2004 63
2005 43
2006 54
2007 78
2008 100
2009 87
2010 85
2011 78
2012 96
2013 88
2014 86
2015 89
2016 81
2017 102
2018 108
2019 110
2020 117
2021 125
2022 135
2023 122
2024 108

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,162 results

Results by year

Filters applied: . Clear all
Page 1
Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J. Abu-Rustum NR, et al. Among authors: ueda s. J Natl Compr Canc Netw. 2019 Nov 1;17(11):1374-1391. doi: 10.6004/jnccn.2019.0053. J Natl Compr Canc Netw. 2019. PMID: 31693991
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: ueda s. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial.
Hironaka S, Ueda S, Yasui H, Nishina T, Tsuda M, Tsumura T, Sugimoto N, Shimodaira H, Tokunaga S, Moriwaki T, Esaki T, Nagase M, Fujitani K, Yamaguchi K, Ura T, Hamamoto Y, Morita S, Okamoto I, Boku N, Hyodo I. Hironaka S, et al. Among authors: ueda s. J Clin Oncol. 2013 Dec 10;31(35):4438-44. doi: 10.1200/JCO.2012.48.5805. Epub 2013 Nov 4. J Clin Oncol. 2013. PMID: 24190112 Clinical Trial.
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701.
Kawase T, Imamura H, Goto M, Kimura Y, Ueda S, Matsuyama J, Nishikawa K, Sugimoto N, Fujita J, Tamura T, Fukushima N, Kawakami H, Sakai D, Kurokawa Y, Shimokawa T, Satoh T. Kawase T, et al. Among authors: ueda s. Int J Clin Oncol. 2021 Oct;26(10):1871-1880. doi: 10.1007/s10147-021-01984-y. Epub 2021 Aug 28. Int J Clin Oncol. 2021. PMID: 34453640 Clinical Trial.
[Drug-induced rhabdomyolysis].
Ueda S. Ueda S. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:567-71. Nihon Rinsho. 2007. PMID: 18072348 Review. Japanese. No abstract available.
[Recommendations for ECT Practice, Second Edition].
Motohashi N, Awata S, Isse K, Ueda S, Okubo Y, Okumura M, Kashima H, Kawasaki H, Sameshima T, Sawa Y, Takebayashi M, Hatta K, Wakejima T, Wada K, Yamaguchi N, Yoneda H. Motohashi N, et al. Among authors: ueda s. Seishin Shinkeigaku Zasshi. 2013;115(6):586-600. Seishin Shinkeigaku Zasshi. 2013. PMID: 23944116 Review. Japanese. No abstract available.
PD-L1 Expression Affects Neoantigen Presentation.
Okada M, Shimizu K, Iyoda T, Ueda S, Shinga J, Mochizuki Y, Watanabe T, Ohara O, Fujii SI. Okada M, et al. Among authors: ueda s. iScience. 2020 Jun 26;23(6):101238. doi: 10.1016/j.isci.2020.101238. Epub 2020 Jun 4. iScience. 2020. PMID: 32629606 Free PMC article.
3,162 results